Brenntag

Brenntag

Global distributor of chemicals and logistics

Overview

Brenntag is a global chemical distributor that connects manufacturers with users. It offers distribution, logistics, and value-added services to move chemicals efficiently across a broad network. The company differentiates itself with a large global reach and a wide range of supply-chain services that emphasize efficiency, sustainability, and transparency. Its goal is to help manufacturers reach target markets and ensure customers receive chemicals reliably while maintaining responsible and accountable operations.

Significant Headcount Growth

About Brenntag

Simplify's Rating
Why Brenntag is rated
B-
Rated A on Competitive Edge
Rated B on Growth Potential
Rated D+ on Differentiation

Industries

Industrial & Manufacturing

Company Size

10,001+

Company Stage

IPO

Headquarters

Mülheim an der Ruhr, Germany

Founded

1874

Get referred to Brenntag

Find people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • BYPHAR targets high-growth mAbs, cell therapies, and vaccine manufacturers with regulatory-ready materials from July 2026.
  • Exclusive Evonik distributorship expands Brenntag's pharma supply chain footprint in Central/Eastern Europe and Turkey.
  • EUR 1.5 billion sustainability-linked credit facility reinforces ESG financing and investor confidence amid growth initiatives.

What critics are saying

  • North Carolina sues Brenntag Mid-South for decades of illegal carcinogen discharge into Third Fork Creek near an elementary school.
  • Court mandates a 30-day remediation plan; failure risks asset seizure, facility shutdown, or criminal negligence charges.
  • Toxic discharge in a Black neighborhood threatens Brenntag's DAX ESG listing, sustainability-linked loans, and new pharma contracts.

What makes Brenntag unique

  • Brenntag is the global market leader in chemical distribution with 600 sites across 70 countries.
  • Its new BYPHAR brand unifies GMP-regulated biopharma raw materials into three risk-tiered grades launching July 2026.
  • Brenntag secured exclusive European distribution rights for Evonik's REXIM(R) GMP-grade amino acids across DACH, UK, and France.

Help us improve and share your feedback! Did you find this helpful?

Funding

Total Funding

$2.4B

Above

Industry Average

Funded Over

3 Rounds

Post IPO Debt funding comparison data is currently unavailable. We're working to provide this information soon!
Post IPO Debt Funding Comparison
Coming Soon

Benefits

Paid parental leave

Education assistance program

Employee assistance program

Health Insurance

Dental Insurance

401(k) Company Match

401(k) Retirement Plan

Flexible Work Hours

Gym/Wellness subsidy

Tuition Reimbursement

Stock Price

Growth & Insights and Company News

Headcount

6 month growth

8%

1 year growth

8%

2 year growth

8%
Evonik Industries AG
Jul 15th, 2026
Evonik appoints Brenntag as the exclusive European distributor for REXIM(R) GMP-grade amino acids.

Evonik appoints Brenntag as the exclusive European distributor for REXIM(R) GMP-grade amino acids. * Brenntag to lead market development and distribution of REXIM(R) GMP-grade amino acids across most of Europe * Agreement strengthens customer access to high-quality amino acids for pharmaceutical and biopharmaceutical applications * Distributorship expands reach for GMP-grade amino acids in growing markets Evonik REXIM has entered into an agreement with Brenntag Specialties Pharma for the exclusive distribution of its REXIM(R) GMP-grade amino acids across most of Europe. Under the agreement, Brenntag will assume responsibility for market development and distribution in key regions including the DACH region, the UK, France, Benelux, Scandinavia, Central and Eastern Europe, Israel and Turkey. Italy, Ukraine, the Middle East and Africa are excluded from the agreement. "Our agreement with Brenntag significantly strengthens the market reach for our REXIM(R) amino acids," said Thomas Hermann, head of the REXIM product line at Evonik Health Care. "Brenntag's strong regional footprint, deep customer relationships, and extensive experience in the life-science sector make them an ideal partner. Together, we can provide customers with reliable access to high-quality GMP-grade amino acids and support the fast-growing pharmaceutical and biopharmaceutical markets." Evonik REXIM is a leading supplier of high-quality amino acids, with key production capabilities and supply sources located in Europe. The company combines market leadership in fermentation, bioconversion and synthetic-based manufacturing. Its collaboration with Brenntag supports Evonik's ambition for the REXIM(R) portfolio, expanding its presence in key global markets and providing customers with enhanced local service, technical support, and long-term supply security. "Our collaboration with Evonik reflects Brenntag's commitment to bringing high-value pharmaceutical ingredients and solutions closer to our customers," said Joakim Rehné, President Brenntag Pharma EMEA. "By combining Evonik's world-class expertise in GMP-grade amino acids with Brenntag's extensive market presence, technical capabilities, and regulatory know-how, we are uniquely positioned to support the evolving needs of pharmaceutical and biopharmaceutical manufacturers across the region. Together, we are creating a stronger, more reliable supply network that helps accelerate innovation and ensure patient access to critical therapies." Amino acids are fundamental building blocks of life and essential components of proteins, driving key biochemical and metabolic processes. REXIM(R) provides highly purified natural and non-natural amino acids. Their high quality and reliability make them suitable for a wide range of regulated applications, including medical nutrition, active pharmaceutical ingredients (APIs) and excipients, as well as nutrient components for cell culture media used in biopharmaceutical production. As a partner to the pharmaceutical industry, Evonik offers a broad, versatile portfolio of functional excipients, technologies, and contract manufacturing (CDMO) services for oral and parenteral dosage forms. End-to-end CDMO capabilities for small molecule APIs, highly potent APIs and intermediates, as well as high-quality innovative cell culture solutions (e.g., dipeptides, lipids, carbohydrates, surfactants) are also a cornerstone in Evonik's Health Care portfolio. Further information: Evonik: leading beyond chemistry. About custom solutions.

Haw River Assembly
Jun 12th, 2026
NC sues Brenntag - june 9, 2026.

NC sues Brenntag - june 9, 2026. FOR IMMEDIATE RELEASE june 10, 2026. Haw River Assembly Celebrates as NC Takes Legal Action Against Brenntag for Contaminating Waters in Durham Flowing to Jordan Lake North Carolina Attorney General and DEQ sue Durham chemical distributor over illegal discharge into Third Fork Creek BYNUM, N.C. - Haw River Assembly is celebrating with communities across Durham in regards to news that the North Carolina

McClatchy
Jun 9th, 2026
North Carolina sues Brenntag over alleged water contamination in Durham.

North Carolina sues Brenntag over alleged water contamination in Durham. Jun 9, 2026 The North Carolina Department of Justice and the Department of Environmental Quality filed a lawsuit against Brenntag on June 9, alleging that the company is contaminating state waters at its Durham facility. Attorney General Jeff Jackson said, "Brenntag has had plenty of time and opportunity to clean up its act so that our water doesn't get contaminated - it hasn't. Clean water is a universal right, and we're taking Brenntag to court to protect our water and clean up the damage they've already done." DEQ Secretary Reid Wilson said, "Residents of Durham, and across this state, deserve clean water. It's our job as the state environmental agency to ensure that companies are following the law, and today we take another step toward ensuring that for those living downstream of this facility." According to the complaint filed by state officials, Brenntag is accused of violating North Carolina's water quality laws by endangering an unnamed tributary to Third Fork Creek. This creek passes Burton Magnet Elementary School before flowing through Burton Park and ultimately reaching Jordan Lake. The lawsuit asks the court to require Brenntag to submit a plan within 30 days to eliminate surface water discharge from its facility and remediate past contamination. In April 2025, DEQ received an anonymous complaint regarding chemical leaks, dumping practices, and poor housekeeping at Brenntag's Durham location. Inspectors found chemicals stored in drums and tanks - some leaking or compromised - and observed contaminated groundwater accumulating around the site with evidence of contaminants entering a local tributary. Water samples confirmed violations of surface water standards. Although DEQ issued a notice requiring immediate action from Brenntag, subsequent inspections found continued violations with no corrective action plan submitted by the company. The North Carolina State Executive Attorney General aims to prevent crime, assist law enforcement, protect consumers, defend residents' rights statewide, represent agencies in court proceedings including criminal appeals, and handle regulatory matters for North Carolina government entities such as legal representation or consumer protection services - all functions outlined on the official website.

EIN News
Apr 3rd, 2026
The Chlorine Institute recognizes Mike Croke with Peter mayo award and names Ken Jones an Honorary Member.

The Chlorine Institute recognizes Mike Croke with Peter mayo award and names Ken Jones an Honorary Member. Mike Croke (right) accepting Peter M. Mayo award from John Eskew (left) at the CI Annual Meeting in Houston, TX Ken Jones, former CI Board Chair, speaking at CI's 100th Anniversary Celebration in New Orleans, LA in 2024 Chlorine Institute Logo CI honors Mike Croke of JCI Jones Chemicals, Inc. and Ken Jones of Brenntag North America, Inc. for leadership and lasting contributions to safety. ARLINGTON, VA, UNITED STATES, April 3, 2026 / EINPresswire.com / - The Chlorine Institute (CI) is pleased to announce that Mike Croke, Vice President of the Southern Region of JCI Jones, is the recipient of the Peter M. Mayo Award. At the same time, it was announced that Ken Jones, of Brenntag North America, Inc. has been named an Honorary Member of The Chlorine Institute for his outstanding contributions to the industry. These awards were presented by CI Board Chair Mr. John Eskew (Occidental Chemical Corporation) at the Institute's 2026 Annual Meeting in Houston, TX. Established in 2005, the Peter M. Mayo Award honors the legacy of Peter M. Mayo - a longtime CI member, former Chair of the Storage and Transport Committee, and a steadfast advocate for safety who contributed more than 30 years of service to the Institute. The award is presented annually to an individual who exemplifies exceptional dedication, collaboration, and commitment to advancing safety across the chlor-alkali value chain. This year's recipient has built a distinguished career marked by operational expertise, leadership, and an ongoing commitment to safety. Over the past 13 years, he has played a vital role on CI's Emergency Preparedness Issue Team (EPIT) and currently serves as its Chair, contributing extensively to CI's CHLOREP and TRANSCAER training programs. His leadership was particularly evident during one of CI's largest TRANSCAER hazardous materials training events, held in Charlotte in 2025, which brought together 212 emergency responders from 29 organizations. Through mentorship, hands-on instruction, and a genuine commitment to strengthening partnerships between industry and first responders, he has embodied CI's mission and values while helping to make the industry safer and more resilient. For his outstanding service, leadership, and advocacy for safety, The Chlorine Institute is proud to recognize Mike Croke of JCI Jones Chemicals, Inc. as the 2026 recipient of the Peter M. Mayo Award. The Chlorine Institute also recognized a distinguished leader with one of its highest honors - Honorary Membership in The Chlorine Institute. Honorary Membership is among the most distinguished recognitions The Chlorine Institute offers. Across 101 years, only 14 individuals have earned this honor, reserved for those whose enduring service and dedication have significantly strengthened the Institute and its mission. Honorees are nominated and elected by the CI Board of Directors. Honorary Membership is reserved for individuals whose service leaves a meaningful and enduring mark. Through years of leadership and dedication, this recipient has exemplified the values and mission of The Chlorine Institute. In recognition of his service, leadership, and commitment to CI, The Chlorine Institute is proud to welcome Ken Jones of Brenntag North America, Inc. as its newest Honorary Member. The Chlorine Institute exists to support the chlor-alkali industry in advancing safe, secure, environmentally compatible and sustainable production, distribution and use of its mission chemicals: chlorine, sodium and potassium hydroxides, sodium hypochlorite, the distribution of vinyl chloride monomer (VCM), and the distribution and use of hydrogen chloride. Visit us online at: www.chlorineinstitute.org.

European Business Services Association
Mar 30th, 2026
Brenntag expands GBS in Łódź.

Brenntag expands GBS in Łódź. Germany-based Brenntag SE is expanding its business services footprint in central Poland, with growing Shared Services activity in the Łódź region (Zgierz). Zaneta Leduchowska is taking the role of Head of the Center. Recent job listings confirm Brenntag is building out core SSC functions, including: * P2P (Accounts Payable & T&E) roles * Order-to-Cash (Credit Control) analysts * Senior finance positions with SSC experience required

Recently Posted Jobs

Sign up to get curated job recommendations

Brenntag is Hiring for 103 Jobs on Simplify!

Find jobs on Simplify and start your career today

Don't see your dream role? Check out thousands of other roles on Simplify. Browse all jobs →